Gene · 5608
Papers2,492
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,281 to 1,300 of 2,492
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Kinase modulation of androgen receptor signaling: implications for prostate cancer. | Cancer Cell Microenviron | 2015 | 28580371 | PubTator, text mining | PubMed |
| Fluorescent Reporters and Biosensors for Probing the Dynamic Behavior of Protein Kinases. | Proteomes | 2015 | 28248276 | PubTator, text mining | PubMed |
| Application of 212Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation. | AIMS Med Sci | 2015 | 26858987 | PubTator, text mining | PubMed |
| Unravelling druggable signalling networks that control F508del-CFTR proteostasis. | Elife | 2015 | 26701908 | PubTator, text mining | PubMed |
| Morphological and molecular characterization of the human breast epithelial cell line M13SV1 and its tumorigenic derivatives M13SV1-R2-2 and M13SV1-R2-N1. | Cancer Cell Int | 2015 | 26612978 | PubTator, text mining | PubMed |
| Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers. | J Bone Oncol | 2015 | 26579483 | PubTator, text mining | PubMed |
| Proteomic Study to Survey the CIGB-552 Antitumor Effect. | Biomed Res Int | 2015 | 26576414 | PubTator, text mining | PubMed |
| Peripheral Blood Mononuclear Cell Gene Expression Remains Broadly Altered Years after Successful Interferon-Based Hepatitis C Virus Treatment. | J Immunol Res | 2015 | 26568966 | PubTator, text mining | PubMed |
| The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation. | Biomed Res Int | 2015 | 26558278 | PubTator, text mining | PubMed |
| Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2. | Oncotarget | 2015 | 26556864 | PubTator, text mining | PubMed |
| Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer. | PLoS One | 2015 | 26556242 | PubTator, text mining | PubMed |
| Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation. | BMC Cancer | 2015 | 26555773 | PubTator, text mining | PubMed |
| Systematic discovery of linear binding motifs targeting an ancient protein interaction surface on MAP kinases. | Mol Syst Biol | 2015 | 26538579 | PubTator, text mining | PubMed |
| EP2 Induces p38 Phosphorylation via the Activation of Src in HEK 293 Cells. | Biomol Ther (Seoul) | 2015 | 26535079 | PubTator, text mining | PubMed |
| Deficiency of hyaluronan synthase 1 (Has1) results in chronic joint inflammation and widespread intra-articular fibrosis in a murine model of knee joint cartilage damage. | Osteoarthritis Cartilage | 2015 | 26521733 | PubTator, text mining | PubMed |
| Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies. | Cancer Metastasis Rev | 2015 | 26516076 | PubTator, text mining | PubMed |
| Identifying New Candidate Genes and Chemicals Related to Prostate Cancer Using a Hybrid Network and Shortest Path Approach. | Comput Math Methods Med | 2015 | 26504486 | PubTator, text mining | PubMed |
| Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling. | Oncotarget | 2015 | 26497681 | PubTator, text mining | PubMed |
| Delivery of Constitutively Active Mutant MKK6(E) With TAT-OSBP Induces Apoptosis in Human Ovarian Carcinoma HO8910 Cells. | Int J Gynecol Cancer | 2015 | 26495757 | PubTator, text mining | PubMed |
| [Study of Mechanism of Esophageal Cancer Development through MKK6 Over-expression Regulated SIRTI Expression Level]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2015 | 26480656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5608/papers?page=65